Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands
Book Now
Menu
Book

Steffen-Sebastian Bolz
CSO at Aphaia Pharma
Speaker

Profile

Steffen-Sebastian Bolz is a scientist, physician and entrepreneur. He is a Co-Founder of Aphaia Pharma AG and Founder and Chief Scientific and Medical Officer at Qanatpharma AG. Steffen-Sebastian holds a full professorship at the University of Toronto, is a Principal Investigator at the Ted Rogers Centre for Heart Research and is Director of the Toronto Centre for Microvascular Medicine. His research program has contributed novel signaling paradigms, methodological advancements and validated innovative molecular/therapeutic targets in the emerging field of microvascular medicine. Steffen-Sebastian holds a medical degree and a doctorate from the universities of Lübeck and Munich, Germany

Agenda Sessions

  • Keynote Panel: From Lab to Launch - Navigating the European Obesity Therapeutics Landscape

    , 09:10
    View Session

  • Presentation: Enteroendocrine Cell Activation via Beaded Oral Glucose: A Multi-Hormonal Approach to Metabolic Regulation

    , 14:15
    View Session

At this event

Prev
Next
Dr. Sergey Tsukanov, PhD
Senior Director Chemistry
Eli Lilly and Company

See Steffen-Sebastian at TIDES Europe: Oligonucleotide and Peptide Therapeutics

Book Now